Free Medical Billing Audit

Colonoscopy & GI Endoscopy Billing Services

Colonoscopy and GI endoscopy billing hinges on one distinction most other specialties never face: whether a procedure is screening or diagnostic, and what happens to the claim and the patient’s cost-sharing when a screening colonoscopy becomes diagnostic mid-procedure. Add the coordination of anesthesia, the separate pathology on removed tissue, and the split between the facility and professional claim in an ASC, and GI endoscopy becomes one of the most modifier-sensitive areas in billing. Mednex Group supports GI endoscopy billing as process and responsibility: verifying benefits before the procedure, applying the screening and conversion modifiers correctly, coordinating anesthesia and pathology, and working the denials. Mednex cannot promise payer decisions or reimbursement.

Open-plan office with white desks
On this page
  1. What colonoscopy and GI endoscopy billing involves
  2. Who this affects
  3. Common codes and what they usually mean
  4. The screening-to-diagnostic conversion
  5. Anesthesia, pathology, and the facility split
  6. Anesthesia
  7. Pathology
  8. ASC facility versus professional
  9. Common denial patterns
  10. Investigation steps when claims go unpaid
  11. How Mednex works with GI practices
  12. Mednex and practice responsibilities
  13. Records and access needed
  14. Quality checks and exceptions
  15. How progress is measured
  16. What cannot be promised
  17. Sources to verify
  18. Frequently asked questions
  19. What do colonoscopy and GI endoscopy billing services include?
  20. What happens when a screening colonoscopy becomes diagnostic?
  21. Why do patients get unexpected bills after a screening colonoscopy?
  22. How are ASC and professional claims handled?
  23. Is pathology billed with the colonoscopy?
  24. How is GI endoscopy billing priced?
  25. Next steps

What colonoscopy and GI endoscopy billing involves

A colonoscopy can be ordered as a screening (a covered preventive benefit for eligible patients) or as a diagnostic study for symptoms, and the same procedure can start as one and end as the other when a polyp is found and removed. That single fact drives the coding, the modifiers, and — critically — what the patient owes, because preventive screening is often cost-free to the patient while a diagnostic procedure is not. Getting the screening-versus-diagnostic story right, and documenting the conversion when it happens, is the center of GI billing.

Beyond colonoscopy, the endoscopy family includes upper endoscopy (EGD), flexible sigmoidoscopy, and therapeutic procedures, each with its own base codes, bundling, and documentation needs.

Who this affects

Gastroenterology practices, GI groups that own or use an ambulatory surgery center, and multispecialty groups with an endoscopy suite. High procedure volume means a recurring coding or modifier habit — mis-handling a screening-to-diagnostic conversion, forgetting the screening modifier, or mis-splitting the ASC facility and professional claims — repeats across hundreds of cases and shows up both as denials and as patient-billing complaints.

Common codes and what they usually mean

Confirm current descriptors, modifiers, and payer policy before billing.

  • 45378 — diagnostic colonoscopy (base code, with or without collection of specimens by washing).
  • 45380 — colonoscopy with biopsy.
  • 45385 — colonoscopy with removal of lesion by snare technique.
  • 45384 / 45388 — colonoscopy with removal by hot biopsy forceps, and with ablation.
  • G0105 / G0121 — screening colonoscopy for high-risk and average-risk Medicare patients.
  • 43235 and family — upper GI endoscopy (EGD), diagnostic and therapeutic variants.

Modifiers matter as much as the base code here: modifier 33 (preventive service) and modifier PT (screening colonoscopy converted to diagnostic) tell the payer how to apply benefits, and getting them wrong changes both the payment and the patient’s balance.

The screening-to-diagnostic conversion

When a colonoscopy is scheduled as screening and the physician finds and removes a polyp, the procedure becomes therapeutic, but it began as a screening — and payers have specific rules, often involving modifier 33 or PT, to preserve some of the preventive benefit so the patient is not surprised by a large bill. The errors here are expensive in two directions: code it as purely diagnostic and the patient is billed cost-sharing they may have been protected from; code it as purely screening and the therapeutic work is under-reported. The documentation has to establish the intent (screening) and the finding (polyp removed), and the modifier has to match.

Anesthesia, pathology, and the facility split

Anesthesia

Monitored anesthesia care for endoscopy is billed by the anesthesia provider with its own codes and, like the procedure, is affected by whether the case was screening or diagnostic. Coordinating the anesthesia claim with the endoscopy claim prevents mismatches that confuse patients and payers.

Pathology

Tissue removed during the procedure is examined and billed separately by the pathologist. The endoscopy claim and the pathology claim are different services; the practice’s billing has to account for both without conflating them.

ASC facility versus professional

When the procedure is done in an ambulatory surgery center, the facility claim (the ASC’s charge) and the professional claim (the physician’s work) are separate, run on different fee schedules, and must be routed correctly. A practice that owns its ASC bills both sides and has to keep them straight.

Common denial patterns

  • Screening/diagnostic modifier errors — missing modifier 33 or PT on a converted screening.
  • Benefit and eligibility — screening billed for a patient outside the covered interval or risk category.
  • Facility/professional mix-ups — ASC and professional charges routed incorrectly.
  • Bundling — components of a therapeutic procedure billed separately.
  • Anesthesia mismatch — anesthesia claim coded inconsistently with the procedure.
  • Frequency — screening frequency limits exceeded for the payer.

Investigation steps when claims go unpaid

The check runs in order: confirm the patient’s screening eligibility and interval; confirm whether the procedure was screening, diagnostic, or converted, and that the modifier matches; confirm facility and professional claims were routed correctly; confirm anesthesia and pathology were handled as separate services; then review bundling and frequency. GI denials concentrate in the screening/conversion logic, so that is checked first.

How Mednex works with GI practices

Mednex verifies benefits before the procedure so the screening-versus-diagnostic question is answered up front, applies the conversion modifiers correctly when a polyp is removed, coordinates the professional, facility, anesthesia, and pathology claims, and works denials and patient-billing disputes. The practice gets reporting on denial reasons and on patient-balance issues tied to conversions. Mednex works inside the existing EHR, endoscopy, and ASC systems.

Mednex and practice responsibilities

Mednex does not perform procedures or decide clinical indications. Mednex verifies benefits, applies the correct screening and conversion coding, routes facility and professional claims, and works denials. The physician owns the procedure and documentation. Mednex is not a law firm; coverage and contract disputes that become legal matters are for the practice’s counsel.

Records and access needed

  • Access to the EHR, endoscopy reporting, and ASC billing systems.
  • Procedure notes documenting screening intent and any findings removed.
  • Benefit and eligibility information for screening coverage.
  • The payer mix and screening frequency and conversion policies.
  • Anesthesia and pathology coordination details.

No protected health information is collected through this website. When records are needed, they move through a secure workflow under a signed business associate agreement.

Quality checks and exceptions

Before submission, claims are checked for screening eligibility, correct screening/conversion modifiers, proper facility/professional routing, and anesthesia/pathology consistency. Exceptions — a borderline screening interval, an unusual conversion, a therapeutic procedure with multiple components — are flagged for review.

How progress is measured

Performance is measured on clean-claim rate, conversion-modifier accuracy, denial reasons, and patient-balance disputes tied to screening — not on a revenue promise. These show whether the gap is benefit verification, modifier logic, or claim routing.

What cannot be promised

  • That a payer will cover a given screening or interval.
  • That a specific amount of revenue will result.
  • That a converted procedure will carry no patient cost-sharing — that depends on the payer’s rules.
  • That a frequency denial will overturn on appeal.

Sources to verify

Screening coverage, modifiers, and endoscopy codes change. Before relying on any statement here for a claim, verify against current primary sources: the Medicare Physician Fee Schedule, CMS preventive-services and colorectal-screening guidance, the CMS Medicare Coverage Database, and the specific payer’s screening and conversion policy.

Frequently asked questions

What do colonoscopy and GI endoscopy billing services include?

Benefit verification before the procedure, correct screening and conversion coding, coordination of the professional, facility, anesthesia, and pathology claims, claim submission, and denial and patient-balance dispute work.

What happens when a screening colonoscopy becomes diagnostic?

When a polyp is found and removed, the procedure becomes therapeutic but began as screening. Payers use modifiers such as 33 or PT to apply benefits so the patient is not fully surprised by cost-sharing. The documentation and modifier must reflect the screening intent and the therapeutic finding.

Why do patients get unexpected bills after a screening colonoscopy?

Usually because a conversion was coded as a purely diagnostic procedure without the modifier that preserves part of the preventive benefit. Correct conversion coding is the fix.

How are ASC and professional claims handled?

In an ambulatory surgery center, the facility charge and the physician’s professional charge are separate, run on different fee schedules, and must be routed correctly. Practices that own their ASC bill both sides.

Is pathology billed with the colonoscopy?

No. Tissue removed during the procedure is examined and billed separately by the pathologist; it is a distinct service from the endoscopy claim.

How is GI endoscopy billing priced?

Pricing depends on procedure volume, ASC involvement, and current denial and conversion performance. Mednex reviews a sample before proposing scope. Start with a free billing audit.

Next steps

If screening conversions generate patient complaints and denials, or ASC and professional claims get tangled, a free medical billing audit will show the pattern. Mednex reviews a sample of endoscopy cases and denials and sends a written summary. No patient information is needed to begin. This pairs with gastroenterology billing, medical billing, A/R recovery, and denial management; or contact Mednex.


See where your revenue cycle stands

Request the free medical billing audit. You receive a written summary of findings and a walkthrough call. No obligation, and no patient information is needed to start.

Do not include patient names, insurance IDs or clinical details. If records are needed later, we set up a secure way to share them.